VISCERAL LEISHMANIASIS

VISCERAL LEISHMANIASIS was reported 722 times

VISCERAL LEISHMANIASIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Lipid-based Polyene Antifungal [EPC] 46 0.0036
1 Sphingosine 1-phosphate Receptor Modulator [EPC] 34 0.0025
2 SLAMF7-directed Immunostimulatory Antibody [EPC] 8 0.0015
3 Antimetabolite Immunosuppressant [EPC] 32 0.0015
4 Polyene Antifungal [EPC] 46 0.0011
5 Lymphocyte Growth Factor [EPC] 1 0.0008
6 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 19 0.0008
7 Dihydrofolate Reductase Inhibitor Antimalarial [EPC] 1 0.0008
8 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 38 0.0008
9 Lipopeptide Antibacterial [EPC] 6 0.0006
10 CD30-directed Immunoconjugate [EPC] 6 0.0006
11 Protease Inhibitor [EPC] 21 0.0005
12 Blood Viscosity Reducer [EPC] 2 0.0005
13 Purine Antimetabolite [EPC] 44 0.0004
14 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 46 0.0004
15 Interleukin-1 Receptor Antagonist [EPC] 7 0.0004
16 Folate Analog Metabolic Inhibitor [EPC] 173 0.0004
17 Proteasome Inhibitor [EPC] 41 0.0004
18 Cytochrome P450 3A Inhibitor [EPC] 20 0.0003
19 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 7 0.0003
20 Penem Antibacterial [EPC] 10 0.0003
21 Corticosteroid [EPC] 340 0.0003
22 Human Immunoglobulin G [EPC] 5 0.0002
23 Calcineurin Inhibitor Immunosuppressant [EPC] 26 0.0002
24 Alkylating Drug [EPC] 38 0.0002
25 Antirheumatic Agent [EPC] 16 0.0002
26 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 17 0.0001
27 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 17 0.0001
28 Tumor Necrosis Factor Blocker [EPC] 132 0.0001
29 Thalidomide Analog [EPC] 68 0.0001
30 Leukocyte Growth Factor [EPC] 18 0.0001
31 Antimycobacterial [EPC] 3 0.0001
32 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 1 0.0001
33 Nuclear Export Inhibitor [EPC] 1 0.0001
34 CD20-directed Cytolytic Antibody [EPC] 36 0.0001
35 Oxazolidinone Antibacterial [EPC] 3 0.0001
36 Xanthine Oxidase Inhibitor [EPC] 14 0.0001
37 Platinum-based Drug [EPC] 21 0.0001
38 Tetracycline-class Drug [EPC] 5 0.0001
39 Fluoroquinolone Antibacterial [EPC] 9 0.0001
40 Aminoglycoside Antibacterial [EPC] 3 0.0001
41 Nucleoside Analog Antiviral [EPC] 5 0.0001
42 Topoisomerase Inhibitor [EPC] 4 0.0001
43 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
44 Kinase Inhibitor [EPC] 23 0.0000
45 Vitamin D [EPC] 12 0.0000
46 Vitamin B12 [EPC] 12 0.0000
47 Aromatic Amino Acid [EPC] 2 0.0000
48 Azole Antifungal [EPC] 5 0.0000
49 Vitamin C [EPC] 13 0.0000
50 Glycopeptide Antibacterial [EPC] 2 0.0000
51 Programmed Death Receptor-1 Blocking Antibody [EPC] 3 0.0000
52 Nonsteroidal Anti-inflammatory Drug [EPC] 38 0.0000
53 Interleukin-6 Receptor Antagonist [EPC] 4 0.0000
54 Proton Pump Inhibitor [EPC] 15 0.0000
55 Janus Kinase Inhibitor [EPC] 4 0.0000
56 RANK Ligand Inhibitor [EPC] 5 0.0000
57 Platelet Aggregation Inhibitor [EPC] 14 0.0000
58 Calcium [EPC] 3 0.0000
59 Nitroimidazole Antimicrobial [EPC] 1 0.0000
60 Selective T Cell Costimulation Modulator [EPC] 2 0.0000
61 Factor Xa Inhibitor [EPC] 3 0.0000
62 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
63 Aminosalicylate [EPC] 1 0.0000
64 Thiazide Diuretic [EPC] 2 0.0000
65 Interleukin-12 Antagonist [EPC] 1 0.0000
66 Interleukin-23 Antagonist [EPC] 1 0.0000
67 Retinoid [EPC] 2 0.0000
68 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
69 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
70 Aldosterone Antagonist [EPC] 1 0.0000
71 Dihydropyridine Calcium Channel Blocker [EPC] 2 0.0000
72 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
73 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
74 Insulin Analog [EPC] 1 0.0000
75 Atypical Antipsychotic [EPC] 1 0.0000
76 Loop Diuretic [EPC] 1 0.0000